Study of Blood Samples From Newborns With Down Syndrome

Conditions

Leukemia

What is the purpose of this trial?

RATIONALE: Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples from newborns with Down syndrome.



Participation Guidelines

Age:
N/A - 1 Year
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Children's Oncology Group
National Cancer Institute (NCI)
Dates:
February 2009
Last Updated:
August 4, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00959283